Previous Article | Next Article ![]()
J. Virol., 06 1996, 3488-3496, Vol 70, No. 6
EK Lium, CA Panagiotidis, X Wen and S Silverstein
During a productive infection by herpes simplex virus type 1 (HSV-1), ICP4,
the major regulatory protein encoded by the alpha4 gene, binds to its
transcription initiation site and represses the accumulation of alpha4 RNA.
Evidence suggests that the degree of repression by ICP4 is a function of
the absolute distance of an ICP4 binding site 3' from a TATA box. However,
repression of HSV-1 gene expression by ICP4 through binding sites located
5' of TATA boxes, as in the case of the alpha0 gene, has not been
adequately addressed. To this end, recombinant alpha0 promoters with
various arrays of ICP4 binding sites flanking the alpha0 TATA box were
constructed and recombined into the HSV-1 genome. Our results demonstrate
the following. (i) Destruction of the endogenous alphaO ICP4 binding site,
located 5' of the TATA box, results in derepression of alpha0 protein and
RNA accumulation in infected Vero cells. (ii) The degree of alpha0
derepression is equivalent to that reported for the alpha4 gene following
destruction of the ICP4 binding site at the alpha4 mRNA cap site in HSV-1.
(iii) Introduction of an ICP4 binding site at the alpha0 mRNA cap site
represses the accumulation of alpha0 RNA greater than threefold relative to
the wild type. (iv) Changes in the abundance of alpha0 protein and RNA in
infected cells do not affect replication or growth of HSV-1 in tissue
culture. Our findings are consistent with the conclusion that alpha0
transcription is repressed by ICP4. These results demonstrate that
repression by ICP4 can occur through binding sites located 5' of virus gene
TATA boxes in HSV-1. Thus, models addressing repression of HSV-1 gene
expression by ICP4 should incorporate the role of binding sites located 5',
as well as 3', of virus gene TATA boxes.
Copyright © 1996, American Society for Microbiology
Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection
Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York 10032, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|